These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 11247247

  • 1. [Immune preparation IRS-19 in the treatment of inflammation in the upper respiratory tracts].
    Gunchikov MV, Vinnikov AK.
    Vestn Otorinolaringol; 2001; (1):40. PubMed ID: 11247247
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Prevention and treatment of upper respiratory tract infections with IRS-19 and polydex with phenylephrine].
    Luchikhin LA, Beliakova LV, Gurov AV.
    Vestn Otorinolaringol; 2000; (4):54-7. PubMed ID: 11011582
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Indications and results of immunostimulation with microbial products in diseases of the upper respiratory tract].
    Seropian E, Ionescu N, Andone C, Filip V.
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1981; 26(1):77-9. PubMed ID: 6454225
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reduction of the number and severity of respiratory tract infections in children by oral immunostimulation.
    Riedl-Seifert RJ, van Aubel A, Kämmereit A, Elsasser U.
    Adv Exp Med Biol; 1995; 371B():799-802. PubMed ID: 7502900
    [No Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of nasal application of CpG oligodeoxynucleotide as a mucosal adjuvant.
    Kodama S, Abe N, Hirano T, Suzuki M.
    Laryngoscope; 2006 Feb; 116(2):331-5. PubMed ID: 16467729
    [Abstract] [Full Text] [Related]

  • 10. [Forced microbial stimulation in respiratory infections].
    Filip V, Brezeanu A, Ionescu M.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986 Feb; 38(4):369-72. PubMed ID: 2879341
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevention of bacterial respiratory infection by a new vaccine, an association of bacterial ribosomes and membranous adjuvants. 1. General remarks.
    Michel FB, Dussourd d'Hinterland L.
    Arzneimittelforschung; 1980 Feb; 30(1a):196-8. PubMed ID: 6892779
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation trial of respiratory bacterial prophylaxis by a ribosomal vaccine. Multicentric double blind study.
    Fumex JP, Michel FB.
    Arzneimittelforschung; 1980 Feb; 30(1a):206-13. PubMed ID: 6989376
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Immunologic stimulation in prevention of bacterial respiratory infection. Trial objective evaluation by changes in serum and sputum Ig(A and G)].
    Michel FB, d'Hinterland LD, Pinel AM, Guendon R, Guerrero A, Préault M.
    Nouv Presse Med; 1975 Feb 01; 4(5):333-6. PubMed ID: 1093123
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.